ALUNA SCIENCE
Live / Applied — New application — not yet assigned to an examiner (as of 03 Jun 2026)
What this means for you
Not registered yet, but its 03 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99863281
- Mark type
- Word mark
- Filed
- 03 Jun 2026
- Attorney of record
- THOMAS E DIETRICH
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for peptide therapy for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders; Pharmaceutical preparations for peptide therapy for the treatment and management of age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Pharmaceutical preparations for the treatment of aging-related conditions, hormone imbalances, and other health conditions via peptide therapy; Pharmaceutical preparations for the treatment and prevention of aging-related conditions; Pharmaceutical preparations for skin care; Therapeutic pharmaceutical for the treatment of aging, hormone imbalance, and other health conditions via peptide therapy; Syringes sold filled with peptide preparations for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders; Syringes sold filled with peptide preparations for the treatment and management of age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; Peptides for the treatment of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders; Peptides for the treatment of age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes
- Class 044 — Medical, beauty and agricultural services: Telemedicine services; Health care services for treating aging and loss of biological function through peptide therapy; Health care consulting in the field of peptide therapy; Providing personalized healthcare and medical information in the nature of peptide therapy; Providing healthy lifestyle and nutrition services, namely, personal assessments, personalized routines, maintenance schedules, and counseling
Owner
- Eterna Technologies Corporation, San Francisco, CA, US
Prosecution history
- 07 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 03 Jun 2026 — NEW APPLICATION ENTERED